sb 202190 and prazosin
sb 202190 has been researched along with prazosin in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Clair, DK; García-Cazarín, ML; Piascik, MT; Smith, JL | 1 |
| Jia, B; Li, H; Lu, D; Lv, X; Peng, X; Wang, F; Wang, H; Wang, Y; Yu, X | 1 |
Other Studies
2 other study(ies) available for sb 202190 and prazosin
| Article | Year |
|---|---|
The alpha1D-adrenergic receptor induces vascular smooth muscle apoptosis via a p53-dependent mechanism.
Topics: Acetophenones; Adrenergic alpha-1 Receptor Antagonists; Anthracenes; Aorta; Apoptosis; Benzothiazoles; Cells, Cultured; Culture Media, Serum-Free; Dioxanes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Humans; Imidazoles; Mitochondria; Muscle, Smooth, Vascular; Phenylephrine; Piperazines; Prazosin; Pyridines; Reactive Oxygen Species; Receptors, Adrenergic, alpha-1; Time Factors; Toluene; Tumor Suppressor Protein p53 | 2008 |
α₁ adrenoceptor activation by norepinephrine inhibits LPS-induced cardiomyocyte TNF-α production via modulating ERK1/2 and NF-κB pathway.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Animals; Animals, Newborn; Butadienes; Endotoxemia; Enzyme Inhibitors; Gene Expression Regulation; Imidazoles; Lipopolysaccharides; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardium; Myocytes, Cardiac; NF-kappa B; Nitriles; Norepinephrine; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Prazosin; Proto-Oncogene Proteins c-fos; Pyridines; Rats; Signal Transduction; Tumor Necrosis Factor-alpha | 2014 |